HOLD at current sizing; trim 30% to 50% on break below 200 SMA at $65.42; no additions until reclaim of $68.85 on volume

• Lower-highs pattern (74.10, 70.10, 68.95) signals weakening demand at higher prices; aggressive analyst's dismissal of this as 'noise' is dangerous
• MACD at 0.01 is a coin flip, not a coiled spring; histogram already negative at minus 0.25 with crossover already occurred
• Sentiment data flagged as low confidence with false positives; bullishness inferred from absence of data is narrative construction, not analysis
• Defensive rotation thesis already priced in after 38% move from $52.81 to $72.89; buying now is late-cycle positioning
• 1.27x FCF coverage is adequate but not fortress; 22% FCF drop would uncover dividend; historical cigarette volume decline of 4% to 5% annually creates structural risk
• PEG of 2.58 vs fair range of 1.0 to 1.5 indicates market is pricing in growth that may not materialize; forward P/E of 11.58 with these risks is concerning
• Add-on-weakness at $65.50-$66.00 offers 20% downside to $52.80 vs 7% upside to $70 target; 3-to-1 unfavorable risk-reward
• 200 SMA held in October 2025 only after 12% break below it; prior holding does not guarantee future support; aggressive analyst citing single episode is insufficient evidence

→ vs aggressive: Lower-highs pattern (74.10, 70.10, 68.95) is not noise but textbook distribution; waiting for confirmation turns small losses into large ones

→ vs aggressive: MACD at zero is ambiguous, not a coiled spring; calling it such is selective interpretation ignoring the possibility of rollover

→ vs aggressive: Bullishness inferred from absence of bad news in hawkish Fed environment is narrative construction from a data vacuum, not analysis

→ vs aggressive: Defensive rotation thesis is already fully expressed after 38% rally; buying now is late-cycle, not early-cycle positioning

→ vs aggressive: 1.27x FCF coverage is adequate, not fortress; 22% FCF drop uncovers dividend; structural pressures (volume decline 4-5% annually, FDA action, GLP-1) could erode this quickly

→ vs aggressive: Cannot cite PEG of 2.58 (vs fair range 1.0-1.5) and forward P/E of 11.58 while simultaneously claiming stock is cheap

→ vs aggressive: Add-on-weakness at $65.50-$66.00 with every momentum indicator bearish, beta potentially rising to 0.8+ in sector liquidation, $1.26B special charge already filed, and earnings in 3 weeks is asymmetric risk, not asymmetric upside

→ vs aggressive: 200 SMA held in October 2025 only after 12% break below it; citing single prior holding as evidence it will always hold is insufficient; same logic failed in Feb 2020 cruise lines, Dec 2021 growth stocks, Jul 2024 regional banks

HOLD with calibrated response framework: maintain position at current sizing, trim 25-30% on confirmed daily close below 65.42 on above-average volume, add 10-15% on confirmed reclaim above 68.85 with MACD histogram turning positive and daily close above 66.50 with declining volume

• 200 SMA at 65.42 is the critical technical level and line in the sand
• Recommended trim is 25-30% on confirmed breakdown—not 50%—to preserve income stream while acknowledging technical deterioration
• Aggressive analyst's risk-reward is 3-to-1 unfavorable: target ~$70 (4% upside) vs October 2025 swing low at $52.80 (22% downside)
• MACD at zero is a coin flip; aggressive analyst's bullish interpretation lacks basis when histogram is negative and price has rolled over
• FCF coverage of 1.27 times is adequate but not robust—a 22% FCF decline would leave dividend uncovered
• Defensive rotation thesis remains intact: Polymarket shows 96% odds of zero Fed cuts in 2026, 10-year at 2002 highs is structural backdrop
• Historical drawdown scenarios (2008, 2018, 2020) required market-wide liquidation events not present in current setup with 8% recession probability
• 200 SMA has historically been a support level with mechanical rebalancing flows and dip buyers—not a guaranteed stop-out
• Add-on-weakness should require confirmed hold and bounce: daily close back above 66.50 with declining volume and constructive candle pattern
• 6.6% dividend yield and inflation pricing power create a real yield floor that differentiates MO from most consumer staples
• Dividend has historically been safe but margin of safety is adequate, not impregnable

→ vs aggressive: Asymmetry argument is mathematically flawed—targeting $70 (4% upside) against October 2025 swing low of $52.80 (22% downside) is a 3-to-1 unfavorable risk-reward, not asymmetric in MO's favor

→ vs aggressive: MACD interpretation at zero is a coin flip; asserting bullish outcome as more probable when histogram is negative and price has rolled over is hope, not analysis

→ vs aggressive: Dividend coverage of 1.27 times FCF is adequate, not fortified—a single historical episode does not make it a fortress when a 22% FCF drop would leave dividend uncovered

→ vs conservative: Defensive rotation thesis has not resolved—Polymarket shows 96% odds of zero Fed cuts in 2026, and 10-year at 2002 highs is structural, not temporary; thesis can persist beyond a single rally

→ vs conservative: Historical drawdown framing misses current context—2008, 2018, and 2020 drawdowns occurred in correlated market-wide liquidation events, not the current regime with 8% recession probability and Fed on hold

→ vs conservative: 50% trim on single daily close below 65.42 is too aggressive and bakes in regime change before confirmed; 25-30% trim is appropriate to respect 200 SMA as watched institutional level with rebalancing flows